Your browser doesn't support javascript.
loading
Functional Antagonism of Junctional Adhesion Molecule-A (JAM-A), Overexpressed in Breast Ductal Carcinoma In Situ (DCIS), Reduces HER2-Positive Tumor Progression.
Smith, Yvonne E; Wang, Guannan; Flynn, Ciara L; Madden, Stephen F; MacEneaney, Owen; Cruz, Rodrigo G B; Richards, Cathy E; Jahns, Hanne; Brennan, Marian; Cremona, Mattia; Hennessy, Bryan T; Sheehan, Katherine; Casucci, Alexander; Sani, Faizah A; Hudson, Lance; Fay, Joanna; Vellanki, Sri H; O'Flaherty, Siobhan; Devocelle, Marc; Hill, Arnold D K; Brennan, Kieran; Sukumar, Saraswati; Hopkins, Ann M.
Afiliação
  • Smith YE; Department of Surgery, RCSI University of Medicine and Health Sciences, Beaumont Hospital, Dublin 9, Ireland.
  • Wang G; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.
  • Flynn CL; Department of Surgery, RCSI University of Medicine and Health Sciences, Beaumont Hospital, Dublin 9, Ireland.
  • Madden SF; Data Science Centre, RCSI University of Medicine and Health Sciences, Dublin 2, Ireland.
  • MacEneaney O; Department of Pathology, RCSI University of Medicine and Health Sciences, Beaumont Hospital, Dublin 9, Ireland.
  • Cruz RGB; Department of Surgery, RCSI University of Medicine and Health Sciences, Beaumont Hospital, Dublin 9, Ireland.
  • Richards CE; Department of Surgery, RCSI University of Medicine and Health Sciences, Beaumont Hospital, Dublin 9, Ireland.
  • Jahns H; School of Veterinary Medicine, University College Dublin, Dublin 4, Ireland.
  • Brennan M; School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin 2, Ireland.
  • Cremona M; Department of Medical Oncology, RCSI University of Medicine and Health Sciences, Beaumont Hospital, Dublin 9, Ireland.
  • Hennessy BT; Department of Medical Oncology, RCSI University of Medicine and Health Sciences, Beaumont Hospital, Dublin 9, Ireland.
  • Sheehan K; Department of Pathology, RCSI University of Medicine and Health Sciences, Beaumont Hospital, Dublin 9, Ireland.
  • Casucci A; School of Medicine, RCSI University of Medicine and Health Sciences, Dublin 2, Ireland.
  • Sani FA; School of Medicine, RCSI University of Medicine and Health Sciences, Dublin 2, Ireland.
  • Hudson L; Department of Surgery, RCSI University of Medicine and Health Sciences, Beaumont Hospital, Dublin 9, Ireland.
  • Fay J; Department of Pathology, RCSI University of Medicine and Health Sciences, Beaumont Hospital, Dublin 9, Ireland.
  • Vellanki SH; Department of Surgery, RCSI University of Medicine and Health Sciences, Beaumont Hospital, Dublin 9, Ireland.
  • O'Flaherty S; Department of Chemistry, RCSI University of Medicine and Health Sciences, Dublin 2, Ireland.
  • Devocelle M; Department of Chemistry, RCSI University of Medicine and Health Sciences, Dublin 2, Ireland.
  • Hill ADK; Department of Surgery, RCSI University of Medicine and Health Sciences, Beaumont Hospital, Dublin 9, Ireland.
  • Brennan K; Department of Surgery, RCSI University of Medicine and Health Sciences, Beaumont Hospital, Dublin 9, Ireland.
  • Sukumar S; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.
  • Hopkins AM; Department of Surgery, RCSI University of Medicine and Health Sciences, Beaumont Hospital, Dublin 9, Ireland.
Cancers (Basel) ; 14(5)2022 Mar 03.
Article em En | MEDLINE | ID: mdl-35267611
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2022 Tipo de documento: Article